About Biotex
Biotex is a company based in United States founded in 1997. It operates as a Direct-to-Consumer (D2C) and Professional Services. Biotex has raised $11.12 million across 33 funding rounds from investors including HHS and National Science Foundation. Biotex offers products and services including Visualase, Phasor Health, and Redpoint.
- Headquarter United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Biotex Inc.
-
Annual Revenue
$197.48 K (USD)-10as on Dec 31, 2022
-
Net Profit
$32.67 (USD)-79as on Dec 31, 2022
-
EBITDA
Not available
-
Total Equity Funding
$11.12 M (USD)
in 33 rounds
-
Latest Funding Round
$10.13 M (USD), Series A
Apr 05, 2024
-
Investors
HHS
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biotex
Biotex offers a comprehensive portfolio of products and services, including Visualase, Phasor Health, and Redpoint.
Non-invasive thermal ablation system for seizure treatment.
FDA-cleared disposable drill with ergonomic design.
Ultra-sensitive device for nanoscale biochemical analysis.
People of Biotex
Unlock access to complete
Unlock access to complete
Funding Insights of Biotex
Biotex has successfully raised a total of $11.12M across 33 strategic funding rounds. The most recent funding activity was a Series A round of $10.13 million completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Biotex
Biotex has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
A government-backed foundation providing seed-stage investments to support small businesses.
|
Locked | Locked | Locked |
Investor details for Biotex
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biotex
Investment portfolio details for Biotex
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Biotex
Detailed financials for Biotex
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biotex Comparisons
Peer comparison for Biotex
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Biotex
Detailed competitors of Biotex
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biotex
Complete news archive for Biotex
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biotex
Biotex was founded in 1997 and raised its 1st funding round 9 years after it was founded.
Biotex is headquartered in United States.
Biotex is a funded company, having raised a total of $11.12M across 33 funding rounds to date.
Annual revenue of Biotex is $197.48K as on Dec 31, 2022.
Biotex is involved in the design, engineering, and manufacturing of medical devices aimed at addressing critical needs in patient care. The company operates within the healthcare sector, offering end-to-end solutions from research and strategy to commercialization. Services provided include product development, pre-clinical testing, clinical trials, regulatory support, and manufacturing. Innovative devices such as Visualase for seizure treatment and Phasor Health for surgical applications are developed to transform healthcare delivery.
Biotex offers Visualase, Phasor Health, and Redpoint.
Biotex has 2 investors. Key investors include HHS, and National Science Foundation.